Sun, Mar 1, 2015, 9:06 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • valuestockinvestor2005 valuestockinvestor2005 Dec 1, 2004 10:01 AM Flag

    What's ELN's take on "oral" Antegren?

    We have yet to hear from them on this. I think if anyone can bring this to market, ELN would be at the forefront. Remember, natalizumab(Tysabri) was a product of ELN's Alzheimer's research, NOT BIIB's!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Oral Antegren is probably not possible because it is a complex protein antibody which would be quickly digested into fragments in the gut.

      A more realistic (and achievable) goal would be an injectable form of antegren, either IM or subcutaneous. Elan has considerable expertise in this area - I could see this happening - and approval would be realtively quick if there were no significant injection site effects - and dosing was achieved.



Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.